Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function

Transplantation Proceedings

Volumn 43, Issue 8, 2011, Pages 3064-3067

  Przybylowski, P ^a   Koc Zorawska, E ^b   Malyszko, J S ^b   Kozlowska, S ^a   Mysliwiec, M ^b   Malyszko, J ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; CYSTATIN C; FATTY ACID BINDING PROTEIN; GLUCOSE;

ADULT; AMINO TERMINAL SEQUENCE; BLOOD CELL COUNT; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HEART TRANSPLANTATION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATINS; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIPOCALINS; LIVER; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 80054748372     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.038     Document Type: Conference Paper

References (14)

1. National Kidney Foundation K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1
2. D.E. Weiner, M. Krassilnikova, and H. Tighiouart CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study BMC Nephrol 10 2009 26
3. A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296
4. A. Kamijo-Ikemori, T. Sugaya, and K. Kimura Urinary fatty acid binding protein in renal disease Clin Chim Acta 374 2006 1
5. Y. Oyama, T. Takeda, and H. Hama Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules Lab Invest 85 2005 522
6. J.M. Thurman, and C.R. Parikh Peeking into the black box: new biomarkers for acute kidney injury Kidney Int 73 2008 379
7. E. Noiri, and K. Doi Urinary fatty acidibinding protein as a biomarker of acute kidney injury Am J Physiol Renal Physiol 296 2009 F669
8. S. Nielsen, T. Sugaya, and L. Tarnow Urinary liver-type fatty acid-binding protein increases with levels of albuminuria in type 1 diabetic patients, and is reduced with ACE inhibition 2008 European Association for the Study of Diabetes Rome, Italy
9. T. Nakamura, T. Sugaya, and Y. Kawagoe Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis Clin Nephrol 65 2006 1
10. Modification of diet in Renal Disease Study Group: Creatinine filtration, secretion and excretion during progressive renal disease Kidney Int 36 1989 S73
11. A.S. Levey, L.A. Stevens, and C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate Prevalence of chronic kidney Intern Med 150 2009 604
12. T. Nakata, A. Hashimoto, and M. Hase Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome Cardiology 99 2003 96
13. M.A. Ferguson, V.S. Vaidya, and S.S. Waikar Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury Kidney Int 77 2010 708
14. T. Yamamoto, E. Noiri, and Y. Ono Renal L-type fatty acidbinding protein in acute ischemic injury J Am Soc Nephrol 18 2007 2894